Lung Cancer

Pope Leo XIV's surgery confirmed that he has lung cancer and he had the lower lobe of his right lung removed, the Vatican said Tuesday. The tests confirmed a diagnosis of lung adenocarcinoma, the Vatican said in a medical bulletin after the surgery. It said the diagnosis had been suspected by preoperative tests and was confirmed during surgery. The 71-year-old was in the operating room for about 3 hours, the statement said. The surgery itself lasted approximately 90 minutes. "The surgery was successful, and there were no complications," the statement said. Pope Leo XIV underwent surgery Tuesday to remove a lung nodule and the Vatican said the operation was completed "successfully, on schedule and as planned." The 71-year-old Leo returned to his room after the surgery at Rome's Gemelli hospital, according to a statement from the Vatican spokesperson, who promised further information at a later time. Leo had walked into Rome's Gemelli hospital through the main entrance earlier in th

Cancers of the respiratory system ranked fifth in India in 2022, with 1,43,062 reported cases. Digestive system cancers and breast cancer remained the top sites.

The combination helped patients with a specific type of advanced non-small cell lung cancer live for 47.5 months at the median, the longest survival benefit ever reported

Experts warn that e-cigarettes may cause hidden lung damage and potentially raise the risk of cancer, especially when used alongside traditional cigarettes

Glenmark Pharmaceuticals on Tuesday said it has launched the lung cancer treatment drug Tevimbra in India, following the approval by the Central Drugs Standard Control Organisation. Tevimbra is developed by BeiGene (now BeOne Medicines), a global oncology leader. This launch marks Glenmark's first foray into immune-oncology in India and is a major milestone in expanding its innovative oncology portfolio, the company said in a regulatory filing. "At a time when the cancer burden is rising sharply, we are proud to enable oncologists and patients to access Tevimbra, a therapy with proven efficacy and safety outcomes, strong science, and meaningful impact," Glenmark Pharmaceuticals President and Business Head India Formulations Alok Malik said. Immuno-oncology offers a promising future for the treatment of various types of advanced cancers, which are difficult to treat, he said, adding that "Our foray in this area marks a significant inflection point in our journey to build a world-clas

Think only smokers get lung cancer? Or that cutting sugar stops cancer growth?

The programme aims to enhance access to targeted cancer therapies by identifying actionable genetic mutations in lung cancer patients

The actor was nominated for two Tony Awards, once for his role in the musical How Now, Dow Jones (1968) and again for Play It Again, Sam

Cases of lung cancer among those who never smoked is on the rise and air pollution could be contributing to the increase, according to a new study. The study was published in The Lancet Respiratory Medicine journal on World Cancer Day on Tuesday. Researchers, including those from the International Agency for Research on Cancer (IARC), World Health Organization, analysed data, including those from the Global Cancer Observatory 2022 dataset, to estimate national-level lung cancer cases for four subtypes -- adenocarcinoma, squamous cell carcinoma, small- and large-cell carcinoma. They found that adenocarcinoma -- a cancer that starts in glands that produce fluids such as mucus and digestive ones -- has become the dominant subtype among both men and women. The sub-type of lung cancer was also found to account for 53-70 per cent of lung cancer cases in 2022 among never-smokers around the world. Compared to the other sub-types of lung cancer, risk of adenocarcinoma is considered to be .

Feedback from the EU indicated that the trial results, which the application was based on, showed that the drug did not significantly improve overall survival for patients

The FDA's so-called complete response letter was related to observations as part of a standard pre-approval inspection at a manufacturing facility

The therapy, branded as Bizengri, targets the NRG1 gene, which is associated with formation and progression of several tumors

Cancer cases in India to surge in India, especially mouth cancer among men and breast cancer among women, reveals ICMR study on BRICS countries

Lung cleansing, or lung detoxification, is said to be the process to clean the lungs of pollutants, toxins and mucus. Here's all you need to know about lung cleansing

Lung cancer happens when the cancer cells start developing in the lungs. To spread awareness among people, World Lung Cancer Day is observed every year on August 1

Around 26 per cent of cancer patients in India have tumours in the head and neck, and there is an upward trend of such cases in the country, a study has found. The findings of the study, conducted on 1,869 cancer patients across the country, were released on the World Head and Neck Cancer Day observed on Saturday. Cancer Mukt Bharat Foundation, a Delhi-based non-profit organisation, conducted the study by collating data from calls received on its helpline number from March 1 to June 30. Dr. Ashish Gupta, a senior oncologist who is heading the Cancer Mukt Bharat Campaign in India, said that India is seeing surge in head and neck cancer cases, especially among young men, due to increased tobacco consumption and human papillomavirus (HPV) infection. "Around 80-90 pc of oral cancer patients have been found to use tobacco in some form, be it smoking or chewing. Most of the head and neck cancer are preventable, unlike other cancers for which the reason is unknown. It is a preventable ..

A recent study highlights the role of poor air quantity in India and genetic diversity in rapidly increasing cases of lung cancer

Imfinzi is a human monoclonal antibody, which works to block a tumour's ability to evade and dampen the immune system, while also boosting the body's anti-cancer immune response

The British drug major is developing next-generation vaccines that have the potential to generate potent and long-lasting immune responses

Lung and bronchus cancer, according to the National Cancer Institute, account for the majority of deaths. Lung cancer was prevalent in about 1,03,371 people in 2022